- Home
- HKPD vs AIDX Comparison
HKPD vs AIDX Comparison
Compare HKPD & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HKPD | AIDX |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | Hong Kong | United States |
| Employees | N/A | 14 |
| Industry | Other Pharmaceuticals | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 4.9M |
| IPO Year | 2024 | 2025 |
Fundamental Metrics
Financial Performance| Metric | HKPD | AIDX |
|---|---|---|
| Price | $0.11 | $0.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 49.5K |
| Earning Date | 08-07-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,045,133.00 |
| Revenue This Year | N/A | $44.20 |
| Revenue Next Year | N/A | $95.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.71 |
| 52 Week Low | $0.10 | $0.40 |
| 52 Week High | $1.68 | $14.09 |
Technical Indicators
Market Signals| Indicator | HKPD | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 28.19 | 41.84 |
| Support Level | $0.10 | $0.40 |
| Resistance Level | $0.70 | $0.49 |
| Average True Range (ATR) | 0.01 | 0.05 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 68.17 | 23.94 |
Price Performance
Historical ComparisonAbout HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.